Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.00 +0.01 (+0.10%) As of 02/21/2025 02:46 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends OACC vs. ORC, AC, NOAH, BRSP, KREF, SITC, ABL, PLYM, PAX, and AACTShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Orchid Island Capital (ORC), Associated Capital Group (AC), Noah (NOAH), BrightSpire Capital (BRSP), KKR Real Estate Finance Trust (KREF), SITE Centers (SITC), Abacus Life (ABL), Plymouth Industrial REIT (PLYM), Patria Investments (PAX), and Ares Acquisition Co. II (AACT). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Orchid Island Capital Associated Capital Group Noah BrightSpire Capital KKR Real Estate Finance Trust SITE Centers Abacus Life Plymouth Industrial REIT Patria Investments Ares Acquisition Co. II Orchid Island Capital (NYSE:ORC) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership. Do institutionals & insiders have more ownership in ORC or OACC? 32.7% of Orchid Island Capital shares are owned by institutional investors. 0.6% of Orchid Island Capital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in ORC or OACC? Orchid Island Capital received 294 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformOrchid Island CapitalOutperform Votes29461.00% Underperform Votes18839.00% Oaktree Acquisition Corp. III Life SciencesN/AN/A Which has stronger valuation & earnings, ORC or OACC? Orchid Island Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrchid Island Capital$177.57M4.68$37.78M$0.6014.86Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A Is ORC or OACC more profitable? Oaktree Acquisition Corp. III Life Sciences' return on equity of 0.00% beat Orchid Island Capital's return on equity.Company Net Margins Return on Equity Return on Assets Orchid Island CapitalN/A -2.01% -0.23% Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A Does the media favor ORC or OACC? In the previous week, Orchid Island Capital had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 1 mentions for Orchid Island Capital and 0 mentions for Oaktree Acquisition Corp. III Life Sciences. Orchid Island Capital's average media sentiment score of 1.67 beat Oaktree Acquisition Corp. III Life Sciences' score of 0.00 indicating that Orchid Island Capital is being referred to more favorably in the media. Company Overall Sentiment Orchid Island Capital Very Positive Oaktree Acquisition Corp. III Life Sciences Neutral Do analysts rate ORC or OACC? Orchid Island Capital currently has a consensus price target of $9.50, suggesting a potential upside of 6.56%. Given Orchid Island Capital's stronger consensus rating and higher probable upside, equities analysts plainly believe Orchid Island Capital is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orchid Island Capital 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryOrchid Island Capital beats Oaktree Acquisition Corp. III Life Sciences on 9 of the 11 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$224.25M$469.79M$1.93B$9.14BDividend YieldN/A6.99%13.61%3.85%P/E RatioN/A2.239.6519.11Price / SalesN/A95.776,694,851.4276.36Price / CashN/A69.0124.7134.83Price / BookN/A4.073.594.62Net IncomeN/A$35.22M-$580.30M$245.85M7 Day Performance-0.10%-0.65%-0.64%-2.61%1 Month PerformanceN/A-4.74%5.86%-2.14%1 Year PerformanceN/A23.41%9.28%12.98% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.00+0.1%N/AN/A$224.25MN/A0.00N/AHigh Trading VolumeORCOrchid Island Capital4.247 of 5 stars$8.97+1.1%$9.50+6.0%+6.5%$838.21M$177.57M14.982,018Positive NewsACAssociated Capital Group2.5161 of 5 stars$38.68+0.2%N/A+17.0%$821.56M$13.18M18.6920Gap DownNOAHNoah3.6888 of 5 stars$12.04+2.2%$13.00+8.0%+2.4%$796.72M$291.18M10.322,583Analyst UpgradeBRSPBrightSpire Capital2.3088 of 5 stars$6.08-0.2%$7.45+22.6%-11.6%$787.81M$244.77M-5.7950Earnings ReportNews CoverageKREFKKR Real Estate Finance Trust4.5177 of 5 stars$11.17-1.0%$12.46+11.5%+15.7%$767.49M$564.63M62.06N/APositive NewsSITCSITE Centers3.7491 of 5 stars$14.63-0.6%$35.75+144.4%-93.5%$766.89M$453.19M1.07270News CoverageABLAbacus Life3.9584 of 5 stars$7.91+4.3%$14.30+80.9%-37.7%$763.94M$79.59M-43.9182PLYMPlymouth Industrial REIT3.3246 of 5 stars$16.45-0.7%$23.89+45.2%-25.1%$746.65M$201.57M822.5040PAXPatria Investments3.3723 of 5 stars$12.17-0.9%$14.00+15.1%-21.7%$728.60M$374.20M24.38390AACTAres Acquisition Co. IIN/A$11.06flatN/A+4.9%$691.25MN/A0.00N/ANews Coverage Related Companies and Tools Related Companies Orchid Island Capital Competitors Associated Capital Group Competitors Noah Competitors BrightSpire Capital Competitors KKR Real Estate Finance Trust Competitors SITE Centers Competitors Abacus Life Competitors Plymouth Industrial REIT Competitors Patria Investments Competitors Ares Acquisition Co. II Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OACC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
